Fluorescite and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Fluorescite (fluorescein sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Enalapril Maleate, and have Diabetic retinopathy.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Fluorescite. It is created by eHealthMe based on reports of 439 people who have side effects when taking Fluorescite from the FDA, and is updated regularly.

What is Fluorescite?

Fluorescite has active ingredients of fluorescein sodium. eHealthMe is studying from 441 Fluorescite users. Check the latest studies of Fluorescite.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,599 drugs and 3,520 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Sep, 01, 2025

439 people reported to have side effects when taking Fluorescite.
Among them, 13 people (2.96%) have Hyperhidrosis.

Among these 13 people:

How long have people been on Fluorescite when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Fluorescite? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Hyperhidrosis when taking Fluorescite? *

What are other drugs people take besides Fluorescite? *

What are other side effects people have besides Hyperhidrosis? *

Weakness: 7 people, 53.85%
Loss Of Consciousness: 6 people, 46.15%
Fatigue (feeling of tiredness): 6 people, 46.15%
Fainting (loss of consciousness and postural tone): 4 people, 30.77%
Dizziness: 4 people, 30.77%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 23.08%
Paleness (unusual lightness of skin colour): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Circulatory Collapse: 3 people, 23.08%
Hypotension (abnormally low blood pressure): 3 people, 23.08%

What are the existing conditions these people have? *

Venous Occlusion (the blocking of venous return): 1 person, 7.69%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 7.69%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 1 person, 7.69%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Fluorescite and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fluorescite:

Fluorescite (441 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,205 reports)

Browse all side effects of Fluorescite:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,599 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,520 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluorescein sodium (the active ingredients of Fluorescite) and Fluorescite (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.